Chyma Oncology (NASDAQ: CHYM) holder files to sell 375,000 common shares

Rhea-AI Filing Summary

Chyma Oncology, Inc. (CHYM) has a shareholder filing to potentially sell up to 375,000 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ, with an indicated aggregate value of $9,720,000.00. The filing lists total common shares outstanding of 348,886,850 as of 08/06/2026.

The securities to be sold include common shares related to 37,102 shares from Restricted Stock Units dated 06/12/2025 and common shares from Previously Exercised Stock Options dated 06/20/2024 for 14,398 shares and 10/10/2019 for 323,500 shares.

Key Figures

Shares to be sold: 375,000 shares Aggregate value: $9,720,000.00 Shares outstanding: 348,886,850 shares +3 more

6 metrics

Shares to be sold 375,000 shares Common stock covered by the Form 144 notice

Aggregate value $9,720,000.00 Indicated aggregate value for 375,000 shares of common stock

Shares outstanding 348,886,850 shares Common shares outstanding as of 08/06/2026

RSU-related shares 37,102 shares Common shares from Restricted Stock Units dated 06/12/2025

Previously exercised options (2024) 14,398 shares Common shares from previously exercised stock options dated 06/20/2024

Previously exercised options (2019) 323,500 shares Common shares from previously exercised stock options dated 10/10/2019

Key Terms

Restricted Stock Units, Previously Exercised Stock Options, Executive Financial Services

3 terms

Restricted Stock Units financial

"Common | 06/12/2025 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Previously Exercised Stock Options financial

"Common | 06/20/2024 | Previously Exercised Stock Options | Issuer"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/06/2026 - 04:27 PM Accepted by SEC EDGAR 08/06/2026 - 04:27 PM Learn about SEC filing dates

FAQ

How many CHYM common shares are covered by this Form 144 filing?

The Form 144 covers a potential sale of 375,000 shares of CHYM common stock with an indicated aggregate value of $9,720,000.00 through Morgan Stanley Smith Barney LLC Executive Financial Services.

What is the aggregate value of CHYM shares in the planned Form 144 sale?

The planned sale covers CHYM common stock with an indicated aggregate value of $9,720,000.00, corresponding to 375,000 shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services.

How many CHYM shares are outstanding according to this Form 144?

The Form 144 states that 348,886,850 CHYM common shares were outstanding as of 08/06/2026; this figure provides context for the size of the potential 375,000-share sale.

What CHYM equity awards are associated with the shares in this Form 144?

The filing lists 37,102 CHYM common shares from Restricted Stock Units dated 06/12/2025 and common shares from Previously Exercised Stock Options dated 06/20/2024 for 14,398 shares and 10/10/2019 for 323,500 shares.

On which market are the CHYM shares in this Form 144 expected to trade?

The Form 144 indicates that the 375,000 CHYM common shares covered by the notice are associated with trading on the NASDAQ, with Morgan Stanley Smith Barney LLC Executive Financial Services as the broker.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	375000	9720000.00	348886850	08/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/12/2025	Restricted Stock Units	Issuer			37102	06/12/2025	N/A
Common	06/20/2024	Previously Exercised Stock Options	Issuer			14398	06/20/2024	Cash
Common	10/10/2019	Previously Exercised Stock Options	Issuer			323500	10/10/2019	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)